UB Paderborn / Katalog / Suche / in CDI

Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial

Clinical microbiology and infection, 2018-08, Vol.24 (8), p.900-907

2018

Link zum Volltext

Verfügbarkeit prüfen

What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada

BMJ open, 2024-04, Vol.14 (4), p.e083453-e083453

2024

Link zum Volltext

Verfügbarkeit prüfen

Analysis of adherence to HIV-positive quality of care indicators and their impact on service quality perceptions in patients: a Spanish cross-sectional study

Health and quality of life outcomes, 2020-06, Vol.18 (1), p.1-185, Article 185

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol

BMJ open, 2023-05, Vol.13 (5), p.e068729-e068729

2023

Link zum Volltext

Verfügbarkeit prüfen

Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717

Journal of antimicrobial chemotherapy, 2018-11, Vol.73 (11), p.2927-2935

2018

Link zum Volltext

Verfügbarkeit prüfen

Determinants of blood telomere length in antiretroviral treatment‐naïve HIV‐positive participants enrolled in the NEAT 001/ANRS 143 clinical trial

HIV medicine, 2019-11, Vol.20 (10), p.691-698

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Journal of antimicrobial chemotherapy, 2019-10, Vol.74 (10), p.3124-3124

2019

Link zum Volltext

Verfügbarkeit prüfen

Inequalities in HIV disease management and progression in migrants from Latin America and sub‐Saharan Africa living in Spain

HIV medicine, 2013-05, Vol.14 (5), p.273-283

2013

Link zum Volltext

Verfügbarkeit prüfen

Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir‐boosted protease inhibitor‐based versus a nonnucleoside reverse transcriptase inhibitor‐based first‐line regimen

HIV medicine, 2014-10, Vol.15 (9), p.547-556

2014

Link zum Volltext

Verfügbarkeit prüfen

Production of Polyclonal Antibodies to the Recombinant Coat Protein of Citrus tristeza virus and their Effectiveness for Virus Detection

Journal of phytopathology, 2008-04, Vol.156 (4), p.243-250

2008

Link zum Volltext

Verfügbarkeit prüfen

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Clinical infectious diseases, 2018-03, Vol.66 (6), p.893-903

2018

Link zum Volltext

Verfügbarkeit prüfen

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1

The Journal of infectious diseases, 2018-10, Vol.218 (10), p.1523-1530

2018

Link zum Volltext

Verfügbarkeit prüfen

Advantages and disadvantages of incorporating qualitative methodology in the evaluation of health services. A practical case: evaluation of a high-resolution clinic

Revista de calidad asistencial, 2012-09, Vol.27 (5), p.275-282

2012

Link zum Volltext

Verfügbarkeit prüfen

Aportaciones e inconvenientes de la incorporación de metodología cualitativa en la evaluación de servicios sanitarios. Un caso práctico: la evaluación de una consulta de alta resolución

Revista de calidad asistencial, 2012-09, Vol.27 (5), p.275-282

2012

Link zum Volltext

Verfügbarkeit prüfen

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

AIDS (London), 2012-11, Vol.26 (17), p.2241-2246

2012

Link zum Volltext

Verfügbarkeit prüfen

Past and future of HIV infection. A document based on expert opinion

Revista española de quimioterapia, 2022-04, Vol.35 (2), p.131-156

2022

Link zum Volltext

Verfügbarkeit prüfen

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1: J Infect Dis

The Journal of infectious diseases, 2018, Vol.218 (10), p.1523-1530

2018

Link zum Volltext

Verfügbarkeit prüfen

Determinants of blood telomere length in antiretroviral treatment-naive HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial: HIV Med

HIV medicine, 2019, Vol.20 (10), p.691-698

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Journal of antimicrobial chemotherapy, 2019-10, Vol.74 (10), p.3044-3048

2019

Link zum Volltext

Verfügbarkeit prüfen

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

The Lancet (British edition), 2010-07, Vol.376 (9738), p.340-345

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients

2010

Link zum Volltext

Verfügbarkeit prüfen

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010

Antiviral therapy, 2013-01, Vol.18 (2), p.161-170

2013

Link zum Volltext

Verfügbarkeit prüfen

What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men?

The Journal of infectious diseases, 2013-04, Vol.207 (8), p.1235-1241

2013

Link zum Volltext

Verfügbarkeit prüfen

How well are we performing the initial assessment of HIV‐positive patients? Results from a multicentre cohort in Spain

HIV medicine, 2020-02, Vol.21 (2), p.128-134

2020

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes

The international journal of tuberculosis and lung disease, 2014-06, Vol.18 (6), p.700-708

2014

Link zum Volltext

Verfügbarkeit prüfen

Inequalities in HIV disease management and progression in migrants from L atin A merica and sub‐ S aharan A frica living in S pain

HIV medicine, 2013-05, Vol.14 (5), p.273-283

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial

What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada

Analysis of adherence to HIV-positive quality of care indicators and their impact on service quality perceptions in patients: a Spanish cross-sectional study

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol

Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717

Determinants of blood telomere length in antiretroviral treatment‐naïve HIV‐positive participants enrolled in the NEAT 001/ANRS 143 clinical trial

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Inequalities in HIV disease management and progression in migrants from Latin America and sub‐Saharan Africa living in Spain

Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir‐boosted protease inhibitor‐based versus a nonnucleoside reverse transcriptase inhibitor‐based first‐line regimen

Production of Polyclonal Antibodies to the Recombinant Coat Protein of Citrus tristeza virus and their Effectiveness for Virus Detection

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1

Advantages and disadvantages of incorporating qualitative methodology in the evaluation of health services. A practical case: evaluation of a high-resolution clinic

Aportaciones e inconvenientes de la incorporación de metodología cualitativa en la evaluación de servicios sanitarios. Un caso práctico: la evaluación de una consulta de alta resolución

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

Past and future of HIV infection. A document based on expert opinion

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1: J Infect Dis

Determinants of blood telomere length in antiretroviral treatment-naive HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial: HIV Med

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010

What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men?

How well are we performing the initial assessment of HIV‐positive patients? Results from a multicentre cohort in Spain

Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes

Inequalities in HIV disease management and progression in migrants from L atin A merica and sub‐ S aharan A frica living in S pain

Suchergebnisse filtern